MYC inhibitor drug targets cancer cells directly and via the immune system
In a series of experiments, researchers have found that an experimental MYC inhibitor drug not only targets lung cancer cells directly but also makes cancer cells easier for the immune system to target and kill.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.